P1038 (10045): A Phase I/II Safety, Tolerability, and Phamacokinetic Study of High-Dose Lopinavir/Ritonavir with or Without Saquinavir in HIV-Infected Pediatric Subjects Previously Treated with Protease Inhibitors

Study Status Study Restriction


Not Applicable

Sites where the study is implemented:

CRS ID Site Name City Country


Boston Medical Center Pediatric HIV Program


United States of America

Study contacts:

No records returned.

CTS: IMPAACT Operations Center


Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.